Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T21:18:05.929Z.
Calculation as of: 2026-10-06T21:18:05.929Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 24a0b8a5defa6360a8df5348432e42fec2fdf5a1d44ff9a0d63a76d612d48360
EARNINGS YIELD
N/A
Market Cap
$1.11B
Earnings Yield
N/A
TTM Avg
0.15%
3Y Avg
0.15%
5Y Avg
0.15%
Market Cap
$1.10B
Earnings Yield
0.36%
TTM Avg
0.35%
3Y Avg
1.14%
5Y Avg
1.02%
Market Cap
$1.13B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.10B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.13B
Earnings Yield
1.30%
TTM Avg
2.76%
3Y Avg
2.15%
5Y Avg
2.02%
Market Cap
$1.09B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Replimune Group, Inc. (REPL) | $1.11B | N/A | N/A | N/A | N/A |
| Tandem Diabetes Care, Inc. (TNDM)vs › | $1.11B | N/A | 0.15% | 0.15% | 0.15% |
| STAAR Surgical Company (STAA)vs › | $1.10B | 0.36% | 0.35% | 1.14% | 1.02% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | N/A | N/A | N/A | N/A |
| Harrow Health, Inc. (HROW)vs › | $1.13B | N/A | 2.62% | 13.63% | 13.63% |
| First Tracks Biotherapeutics Inc (TRAX)vs › | $1.10B | N/A | N/A | N/A | N/A |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.13B | 1.30% | 2.76% | 2.15% | 2.02% |
| OPKO Health, Inc. (OPK)vs › | $1.09B | N/A | 3.24% | 3.19% | 3.19% |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | N/A | N/A | N/A | N/A |
| IRadimed Corporation (IRMD)vs › | $1.08B | 2.11% | 1.90% | 2.54% | 2.45% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
